US4086257A
(en)
*
|
1976-10-12 |
1978-04-25 |
Sears Barry D |
Phosphatidyl quaternary ammonium compounds
|
USRE31609E
(en)
*
|
1976-10-12 |
1984-06-19 |
Lipid Specialties, Inc. |
Method of preparing a controlled-release pharmaceutical preparation, and resulting composition
|
GB1575343A
(en)
*
|
1977-05-10 |
1980-09-17 |
Ici Ltd |
Method for preparing liposome compositions containing biologically active compounds
|
US4460577A
(en)
*
|
1977-09-30 |
1984-07-17 |
Farmitalia Carlo Erba S.P.A. |
Pharmaceutical compositions consisting or consisting essentially of liposomes, and processes for making same
|
US4356167A
(en)
*
|
1978-01-27 |
1982-10-26 |
Sandoz, Inc. |
Liposome drug delivery systems
|
GB2026340B
(en)
*
|
1978-07-03 |
1982-12-22 |
Ash P |
Stabilising microvesicles
|
GB2046092B
(en)
*
|
1979-03-05 |
1983-11-02 |
Toyama Chemical Co Ltd |
Pharmaceutical composition containing a lysophospholid and a phospholipid
|
DE2914788A1
(de)
*
|
1979-04-11 |
1980-10-16 |
Nattermann A & Cie |
Parenteral applizierbare, stabile arzneimittelloesungen mit entzuendungshemmender wirkung
|
DE2914789A1
(de)
*
|
1979-04-11 |
1980-10-16 |
Nattermann A & Cie |
Injizierbare arzneimittel mit entzuendungshemmender wirkung
|
JPS55153713A
(en)
*
|
1979-05-02 |
1980-11-29 |
Kureha Chem Ind Co Ltd |
Pharmaceutical preparation of ribosome containing active substance
|
US4261975A
(en)
*
|
1979-09-19 |
1981-04-14 |
Merck & Co., Inc. |
Viral liposome particle
|
US4341215A
(en)
*
|
1980-09-04 |
1982-07-27 |
Tampax Incorporated |
Absorbent device
|
JPS62682Y2
(fr)
*
|
1980-11-05 |
1987-01-09 |
|
|
JPS5782310A
(en)
*
|
1980-11-11 |
1982-05-22 |
Tanabe Seiyaku Co Ltd |
Production of liposome preparation
|
JPS57109835U
(fr)
*
|
1980-12-26 |
1982-07-07 |
|
|
JPS62684Y2
(fr)
*
|
1980-12-30 |
1987-01-09 |
|
|
JPS5850917Y2
(ja)
*
|
1981-04-24 |
1983-11-19 |
大正製薬株式会社 |
揮発性液剤分与器
|
US4426330A
(en)
*
|
1981-07-20 |
1984-01-17 |
Lipid Specialties, Inc. |
Synthetic phospholipid compounds
|
US4534899A
(en)
*
|
1981-07-20 |
1985-08-13 |
Lipid Specialties, Inc. |
Synthetic phospholipid compounds
|
NL193099C
(nl)
*
|
1981-10-30 |
1998-11-03 |
Novo Industri As |
Gestabiliseerde insuline-oplossing.
|
EP0084898B1
(fr)
*
|
1982-01-22 |
1986-09-03 |
FISONS plc |
Compostions contenant de liposomes et cromoglycate disodique et méthodes de leur préparation
|
US4917897A
(en)
*
|
1982-01-22 |
1990-04-17 |
Fisons Plc |
Pharmaceutical compositions
|
US4452747A
(en)
*
|
1982-03-22 |
1984-06-05 |
Klaus Gersonde |
Method of and arrangement for producing lipid vesicles
|
US4485054A
(en)
*
|
1982-10-04 |
1984-11-27 |
Lipoderm Pharmaceuticals Limited |
Method of encapsulating biologically active materials in multilamellar lipid vesicles (MLV)
|
FR2534487B1
(fr)
*
|
1982-10-15 |
1988-06-10 |
Dior Christian Parfums |
Procede d'homogeneisation de dispersions de phases lamellaires lipidiques hydratees, et suspensions obtenues par ce procede
|
JPS5979137U
(ja)
*
|
1982-11-18 |
1984-05-29 |
株式会社ソ−ラ− |
芳香液容器の蒸散量調節蓋
|
US4515736A
(en)
*
|
1983-05-12 |
1985-05-07 |
The Regents Of The University Of California |
Method for encapsulating materials into liposomes
|
US4725442A
(en)
*
|
1983-06-17 |
1988-02-16 |
Haynes Duncan H |
Microdroplets of water-insoluble drugs and injectable formulations containing same
|
US4532089A
(en)
*
|
1984-01-14 |
1985-07-30 |
Northwestern University |
Method of preparing giant size liposomes
|
EP0152379A3
(fr)
*
|
1984-02-15 |
1986-10-29 |
Ciba-Geigy Ag |
Procédé pour la préparation de compositions pharmaceutiques contenant des liposomes unilamellaires
|
CH668554A5
(de)
*
|
1984-04-09 |
1989-01-13 |
Sandoz Ag |
Liposomen welche polypeptide mit interleukin-2-aktivitaet enthalten sowie verfahren zu ihrer herstellung.
|
US5008050A
(en)
*
|
1984-06-20 |
1991-04-16 |
The Liposome Company, Inc. |
Extrusion technique for producing unilamellar vesicles
|
CA1264668A
(fr)
*
|
1984-06-20 |
1990-01-23 |
Pieter R. Cullis |
Techniques d'extrusion pour la production de liposomes
|
US5077056A
(en)
*
|
1984-08-08 |
1991-12-31 |
The Liposome Company, Inc. |
Encapsulation of antineoplastic agents in liposomes
|
US4880635B1
(en)
*
|
1984-08-08 |
1996-07-02 |
Liposome Company |
Dehydrated liposomes
|
US4897269A
(en)
*
|
1984-09-24 |
1990-01-30 |
Mezei Associates Limited |
Administration of drugs with multiphase liposomal delivery system
|
US4761288A
(en)
*
|
1984-09-24 |
1988-08-02 |
Mezei Associates Limited |
Multiphase liposomal drug delivery system
|
US4622188A
(en)
*
|
1984-12-21 |
1986-11-11 |
E. I. Du Pont De Nemours And Company |
Method for manufacturing liposomes
|
US4737276A
(en)
*
|
1984-12-21 |
1988-04-12 |
E. I. Du Pont De Nemours And Company |
Apparatus for manufacturing liposomes
|
US4857319A
(en)
*
|
1985-01-11 |
1989-08-15 |
The Regents Of The University Of California |
Method for preserving liposomes
|
US4753788A
(en)
*
|
1985-01-31 |
1988-06-28 |
Vestar Research Inc. |
Method for preparing small vesicles using microemulsification
|
US5409704A
(en)
*
|
1985-06-26 |
1995-04-25 |
The Liposome Company, Inc. |
Liposomes comprising aminoglycoside phosphates and methods of production and use
|
US4975282A
(en)
*
|
1985-06-26 |
1990-12-04 |
The Liposome Company, Inc. |
Multilamellar liposomes having improved trapping efficiencies
|
WO1987000043A1
(fr)
*
|
1985-07-05 |
1987-01-15 |
The Liposome Company, Inc. |
Liposomes multilamellaires presentant une efficacite de capture amelioree
|
DE3631824A1
(de)
*
|
1986-02-21 |
1988-03-31 |
Bayer Ag |
Cycloalkano(1.2-b)indol-sulfonamide
|
AU633563B2
(en)
*
|
1986-02-21 |
1993-02-04 |
Bayer Yakuhin, Ltd. |
Cycloalkanonesulphonamides
|
US5371109A
(en)
*
|
1986-07-01 |
1994-12-06 |
Drilletten Ab |
Controlled release composition for a biologically active material dissolved or dispersed in an L2-phase
|
US5133973A
(en)
*
|
1986-08-07 |
1992-07-28 |
Medice Chem.-Pharm. Fabrik Putter Gmbh & Co. Kg |
Pharmaceutical preparations
|
US4776991A
(en)
*
|
1986-08-29 |
1988-10-11 |
The United States Of America As Represented By The Secretary Of The Navy |
Scaled-up production of liposome-encapsulated hemoglobin
|
US4911929A
(en)
*
|
1986-08-29 |
1990-03-27 |
The United States Of America As Represented By The Secretary Of The Navy |
Blood substitute comprising liposome-encapsulated hemoglobin
|
JPS6355914U
(fr)
*
|
1986-09-30 |
1988-04-14 |
|
|
ATE141166T1
(de)
*
|
1986-12-23 |
1996-08-15 |
Liposome Co Inc |
Guanidinaminoglycosid enthaltende liposome
|
EP0414663A4
(en)
*
|
1987-04-16 |
1991-07-17 |
The Liposome Company, Inc. |
Liposome continuous size reduction method and apparatus
|
US4963362A
(en)
*
|
1987-08-07 |
1990-10-16 |
Regents Of The University Of Minnesota |
Freeze-dried liposome mixture containing cyclosporin
|
EP0382777B1
(fr)
*
|
1987-10-19 |
1994-10-12 |
The Liposome Company, Inc. |
Preparation aqueuse de composition de liposomes
|
US4981690A
(en)
*
|
1987-10-27 |
1991-01-01 |
Board Of Regents, The University Of Texas System |
Liposome-incorporated mepartricin
|
US4917892A
(en)
*
|
1988-06-28 |
1990-04-17 |
Temple University |
Encapsulated topical delivery system
|
US4937078A
(en)
*
|
1988-08-26 |
1990-06-26 |
Mezei Associates Limited |
Liposomal local anesthetic and analgesic products
|
DE68916439T2
(de)
*
|
1988-10-05 |
1994-10-20 |
Vestar Inc |
Verfahren zur herstellung von liposomen mit verbesserter stabilität während des trocknens.
|
US6132763A
(en)
*
|
1988-10-20 |
2000-10-17 |
Polymasc Pharmaceuticals Plc |
Liposomes
|
US5015483A
(en)
*
|
1989-02-09 |
1991-05-14 |
Nabisco Brands, Inc. |
Liposome composition for the stabilization of oxidizable substances
|
US5139803A
(en)
*
|
1989-02-09 |
1992-08-18 |
Nabisco, Inc. |
Method and liposome composition for the stabilization of oxidizable substances
|
US5188837A
(en)
*
|
1989-11-13 |
1993-02-23 |
Nova Pharmaceutical Corporation |
Lipsopheres for controlled delivery of substances
|
US5227165A
(en)
*
|
1989-11-13 |
1993-07-13 |
Nova Pharmaceutical Corporation |
Liposphere delivery systems for local anesthetics
|
US5221535A
(en)
*
|
1989-11-13 |
1993-06-22 |
Nova Pharmaceutical Corporation |
Sustained release formulations of insect repellent
|
IE904098A1
(en)
*
|
1989-11-13 |
1991-05-22 |
Nova Pharm Corp |
Lipospheres for controlled delivery of substances
|
WO1992002244A1
(fr)
*
|
1990-07-31 |
1992-02-20 |
The Liposome Company, Inc. |
Accumulation d'acides amines et de peptides dans des liposomes
|
US5834428A
(en)
*
|
1995-04-14 |
1998-11-10 |
1149336 Ontario Inc. |
Glucagon-like peptide-2 and its therapeutic use
|
US5990077A
(en)
|
1995-04-14 |
1999-11-23 |
1149336 Ontario Inc. |
Glucagon-like peptide-2 and its therapeutic use
|
US6184201B1
(en)
|
1995-04-14 |
2001-02-06 |
Nps Allelix Corp. |
Intestinotrophic glucagon-like peptide-2 analogs
|
DE69637441T2
(de)
*
|
1995-10-17 |
2009-03-05 |
Jagotec Ag |
Verabreichung unlöslicher arzneistoffe
|
US6231888B1
(en)
|
1996-01-18 |
2001-05-15 |
Perio Products Ltd. |
Local delivery of non steroidal anti inflammatory drugs (NSAIDS) to the colon as a treatment for colonic polyps
|
US6183774B1
(en)
|
1996-01-31 |
2001-02-06 |
Collaborative Laboratories, Inc. |
Stabilizing vitamin A derivatives by encapsulation in lipid vesicles formed with alkylammonium fatty acid salts
|
US5874105A
(en)
*
|
1996-01-31 |
1999-02-23 |
Collaborative Laboratories, Inc. |
Lipid vesicles formed with alkylammonium fatty acid salts
|
AU733857B2
(en)
|
1996-04-12 |
2001-05-31 |
1149336 Ontario Inc. |
Glucagon-like peptide-2 analogs
|
US6111081A
(en)
*
|
1996-05-31 |
2000-08-29 |
Baylor College Of Medicine |
Lactoferrin variants and uses thereof
|
US6465016B2
(en)
|
1996-08-22 |
2002-10-15 |
Research Triangle Pharmaceuticals |
Cyclosporiine particles
|
US7255877B2
(en)
|
1996-08-22 |
2007-08-14 |
Jagotec Ag |
Fenofibrate microparticles
|
US6037125A
(en)
*
|
1996-11-05 |
2000-03-14 |
Lexicon Genetics Incorporated |
Disruption of the mammalian RAD51 protein and disruption of proteins that associate with mammalian RAD51 for hindering cell proliferation and/or viability of proliferating cells
|
US5968895A
(en)
*
|
1996-12-11 |
1999-10-19 |
Praecis Pharmaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
US20070185032A1
(en)
*
|
1996-12-11 |
2007-08-09 |
Praecis Pharmaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
CA2236519C
(fr)
|
1997-05-02 |
2011-09-13 |
1149336 Ontario Inc. |
Methodes pour ameliorer le fonctionnement du gros intestin
|
IL137734A0
(en)
*
|
1998-02-11 |
2001-10-31 |
Res Triangle Pharm Ltd |
Method and composition for treatment of inflammatory conditions
|
US6228840B1
(en)
|
1998-02-27 |
2001-05-08 |
Edward T. Wei |
Melanocortin receptor antagonists and modulations of melanocortin receptor activity
|
JP2002516267A
(ja)
|
1998-05-29 |
2002-06-04 |
アールティーピー・ファーマ・インコーポレーテッド |
熱的に保護された微粒子組成物及びその最終蒸気滅菌
|
DK1105096T3
(da)
|
1998-08-19 |
2004-03-08 |
Skyepharma Canada Inc |
Injicerbare vandige propofoldispersioner
|
US6855296B1
(en)
|
1998-11-13 |
2005-02-15 |
Optime Therapeutics, Inc. |
Method and apparatus for liposome production
|
IL143104A
(en)
|
1998-11-13 |
2005-09-25 |
Optime Therapeutics Inc |
Method and apparatus for liposome production
|
KR20010073232A
(ko)
*
|
1998-11-20 |
2001-07-31 |
추후제출 |
분산성 인지질로 안정화된 마이크로입자
|
NZ501264A
(en)
|
1998-12-22 |
2001-09-28 |
Pfizer Prod Inc |
Polynucleotide DNA sequence encoding an infectious RNA molecule encoding a North American PRRS
|
US7691389B2
(en)
|
1998-12-22 |
2010-04-06 |
Pfizer Inc |
Infectious cDNA clone of north american porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
|
US7618797B2
(en)
*
|
1998-12-22 |
2009-11-17 |
Pfizer Inc |
Infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
|
US7132106B2
(en)
*
|
1998-12-22 |
2006-11-07 |
Pfizer Inc. |
Infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
|
ES2233284T3
(es)
*
|
1999-02-17 |
2005-06-16 |
Pfizer Products Inc. |
Proteinas de fusion que comprenden portadores que pueden inducir una bdoble respuesta inmune.
|
US6632451B2
(en)
|
1999-06-04 |
2003-10-14 |
Dexcel Pharma Technologies Ltd. |
Delayed total release two pulse gastrointestinal drug delivery system
|
WO2000076982A1
(fr)
|
1999-06-16 |
2000-12-21 |
University Of Iowa Research Foundation |
Antagonisme des oligonucleotides cpg immunostimulateurs par des 4-aminoquinolines et autres bases faibles
|
IL148685A0
(en)
*
|
1999-09-21 |
2002-09-12 |
Rtp Pharma Inc |
Surface modified particulate compositions of biologically active substances
|
US6710038B1
(en)
|
1999-12-14 |
2004-03-23 |
Kibun Food Chemifa Co., Ltd. |
Emulsification method using propylene glycol hyaluronate
|
EP1276465B1
(fr)
|
2000-04-20 |
2014-03-12 |
Jagotec AG |
Procede ameliore destine aux particules de medicament insolubles dans l'eau
|
JP4969761B2
(ja)
|
2000-08-31 |
2012-07-04 |
オバン・エナジー・リミテッド |
所望粒度を持つ固体基材の小粒子および第一材料の小粒状物を含む相乗作用性混合物を製造する方法
|
US8586094B2
(en)
*
|
2000-09-20 |
2013-11-19 |
Jagotec Ag |
Coated tablets
|
WO2002024193A1
(fr)
*
|
2000-09-20 |
2002-03-28 |
Skyepharma Canada Inc. |
Microparticules de fibrate stabilisees
|
SK7092003A3
(en)
*
|
2000-11-09 |
2004-06-08 |
Neopharm Inc |
SN-38 lipid complexes and methods of use
|
US6534088B2
(en)
*
|
2001-02-22 |
2003-03-18 |
Skyepharma Canada Inc. |
Fibrate-statin combinations with reduced fed-fasted effects
|
WO2003030864A1
(fr)
*
|
2001-05-29 |
2003-04-17 |
Neopharm, Inc. |
Formulation liposomale d'irinotecan
|
US6872827B2
(en)
*
|
2002-04-26 |
2005-03-29 |
Chembridge Research Laboratories, Inc. |
Somatostatin analogue compounds
|
WO2004035032A2
(fr)
*
|
2002-08-20 |
2004-04-29 |
Neopharm, Inc. |
Formulation de sn-38 a base de lipides pharmaceutiquement actifs
|
US20060030578A1
(en)
*
|
2002-08-20 |
2006-02-09 |
Neopharm, Inc. |
Pharmaceutically active lipid based formulation of irinotecan
|
US20040224010A1
(en)
*
|
2002-11-15 |
2004-11-11 |
Optime Therapeutics, Inc. |
Ophthalmic liposome compositions and uses thereof
|
US20060193825A1
(en)
*
|
2003-04-29 |
2006-08-31 |
Praecis Phamaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
US20050112087A1
(en)
*
|
2003-04-29 |
2005-05-26 |
Musso Gary F. |
Pharmaceutical formulations for sustained drug delivery
|
KR100651728B1
(ko)
*
|
2004-11-10 |
2006-12-06 |
한국전자통신연구원 |
정착기를 갖는 전자 소자용 화합물 및 이를 포함하는 전자소자와 이들의 제조 방법
|
EP2117575A4
(fr)
|
2007-01-03 |
2013-06-05 |
Burnham Inst Medical Research |
Méthodes et compositions associées à des composés adhérant aux caillots
|
JP5671336B2
(ja)
|
2007-05-08 |
2015-02-18 |
バーナム インスティテュート フォー メディカル リサーチ |
組織非特異的アルカリホスファターゼ阻害因子および血管石灰化を処置するためのそれらの使用
|
US8053553B2
(en)
|
2007-05-09 |
2011-11-08 |
Socpra Sciences Sante Et Humaines |
Targeting host proteinases as a therapeutic strategy against viral and bacterial pathogens
|
US7960336B2
(en)
|
2007-08-03 |
2011-06-14 |
Pharmain Corporation |
Composition for long-acting peptide analogs
|
WO2010070380A2
(fr)
*
|
2007-12-03 |
2010-06-24 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health Of Human Services, National Institutes Of Health |
Compositions doc1 et méthodes de traitement du cancer
|
KR20130054466A
(ko)
*
|
2008-10-16 |
2013-05-24 |
화이자 인코포레이티드 |
토크 테노 바이러스(ttv) 분리물 및 조성물
|
FR2950807B1
(fr)
*
|
2009-10-06 |
2012-02-03 |
Lvmh Rech |
Composition cosmetique contenant des liposomes encapsules dans un compose oxazolidin-2-one
|
US20110081293A1
(en)
|
2009-10-07 |
2011-04-07 |
Sanford-Burnham Medical Research Institute |
Methods and compositions related to clot-binding lipid compounds
|
US8846388B2
(en)
|
2009-10-16 |
2014-09-30 |
Zoetis Llc |
Infectious clones of torque teno virus
|
JP2013515008A
(ja)
|
2009-12-18 |
2013-05-02 |
サンフォード−バーナム メディカル リサーチ インスティテュート |
凝血塊結合化合物に関連する方法および組成物
|
WO2011079304A1
(fr)
|
2009-12-23 |
2011-06-30 |
Sanford-Burnham Medical Research Institute |
Méthodes et compositions se rapportant à des composés se liant à l'annexine 1
|
CA2795289A1
(fr)
|
2010-04-08 |
2011-10-13 |
Sanford-Burnham Medical Research Institute |
Methodes et compositions pour une administration amelioree de composes
|
WO2011123943A1
(fr)
|
2010-04-09 |
2011-10-13 |
Mount Sinai Hospital |
Méthodes de traitement de troubles du tractus gastro-intestinal au moyen d'un agoniste glp-1
|
UA108902C2
(uk)
|
2010-11-10 |
2015-06-25 |
|
Вірус північноамериканського репродуктивного та респіраторного синдрому свиней (prrs) та його застосування
|
WO2012118778A1
(fr)
|
2011-02-28 |
2012-09-07 |
Sanford-Burnham Medical Research Institute |
Peptides car tronqués, procédés et compositions les utilisant
|
EP2718429A1
(fr)
|
2011-06-08 |
2014-04-16 |
Zoetis LLC |
Clones infectieux du virus torque teno
|
US10179801B2
(en)
|
2011-08-26 |
2019-01-15 |
Sanford-Burnham Medical Research Institute |
Truncated LYP-1 peptides and methods and compositions using truncated LYP-1 peptides
|
US8877161B2
(en)
|
2011-10-19 |
2014-11-04 |
Georgia Regents Research Institute, Inc. |
GM1-like peptides and uses thereof
|
WO2013173443A1
(fr)
|
2012-05-17 |
2013-11-21 |
Zoetis Llc |
Vaccination efficace contre le virus du syndrome reproducteur et respiratoire porcin (srrp) avant le sevrage
|
EP4219534A3
(fr)
|
2013-07-08 |
2023-09-27 |
The University of Utah Research Foundation |
Procédés de traitement et de prophylatise contre les troubles inflammatoires
|
EP3313447A2
(fr)
|
2015-06-25 |
2018-05-02 |
Sanford Burnham Prebys Medical Discovery Institute |
Compositions à administrer dans des plaques athéroscléreuses, pour le traitement de ces plaques
|
BR112018069371A2
(pt)
|
2016-03-21 |
2019-01-22 |
South Dakota Board Of Regents |
construção de ácido nucleico, vetor, vacina ou composição imunogênica, método de entrega de uma vacina, método de produção de uma construção de ácido nucleico e método para conferir imunidade contra um antígeno
|
BR112019012158A2
(pt)
|
2016-12-14 |
2019-11-12 |
Zoetis Services Llc |
vacinação eficaz contra cepas europeias de vírus da síndrome reprodutiva e respiratória suína (prrs) antes do desmame
|
EP3628047A1
(fr)
|
2017-05-02 |
2020-04-01 |
Sanford Burnham Prebys Medical Discovery Institute |
Peptide liant des monocytes/macrophages associés à une tumeur et procédés d'utilisation associés
|
WO2018204918A1
(fr)
|
2017-05-05 |
2018-11-08 |
Ardelyx, Inc. |
Traitement de troubles hépatiques
|
US10953085B2
(en)
|
2017-05-09 |
2021-03-23 |
Lawrence Livermore National Security, Llc |
Genetically engineered Foot and Mouth Disease Virus and related proteins, polynucleotides, compositions, methods and systems
|
EP3897954B1
(fr)
*
|
2018-12-21 |
2024-05-01 |
Bracco Suisse SA |
Microvésicules remplies de gaz avec ligand
|
US20220119450A1
(en)
|
2019-02-04 |
2022-04-21 |
University Of Tartu |
Bi-specific extracellular matrix binding peptides and methods of use thereof
|
CN111084387A
(zh)
*
|
2019-12-24 |
2020-05-01 |
李晨悦 |
多功能营养组合物及其制备方法和保健食品
|
CN114315985A
(zh)
|
2020-09-29 |
2022-04-12 |
硕腾服务有限责任公司 |
减毒猪流行性腹泻病毒
|
CN115216451A
(zh)
|
2021-04-16 |
2022-10-21 |
硕腾服务有限责任公司 |
伪狂犬病病毒疫苗
|